CStone Pharmaceuticals (HKG:2616)
Hong Kong · Delayed Price · Currency is HKD 6.02
-0.15 (-2.35%)
Sep 10, 2026, 1:15 PM HKT
CStone Pharmaceuticals Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,395 | 753.7 | 387.94 | 996.67 | 558.68 | 742.72 |
Short-Term Investments | 230.87 | 208.79 | 331.95 | 51.85 | 588.91 | 913.07 |
Trading Asset Securities | - | - | - | - | - | 122.9 |
Cash & Short-Term Investments | 1,626 | 962.49 | 719.88 | 1,049 | 1,148 | 1,779 |
Cash Growth | 135.63% | 33.70% | -31.34% | -8.63% | -35.48% | -50.20% |
Accounts Receivable | 107.36 | 33.81 | 83.93 | 172.44 | 77.13 | 117.6 |
Receivables | 107.36 | 33.81 | 83.93 | 172.44 | 77.13 | 117.6 |
Inventory | 74.17 | 116.89 | 286.1 | 108.83 | 22.19 | 61.36 |
Total Current Assets | 1,808 | 1,113 | 1,090 | 1,330 | 1,247 | 1,958 |
Property, Plant & Equipment | 89.96 | 83.13 | 130.54 | 153.37 | 206.57 | 182.8 |
Long-Term Investments | 4.61 | 4.76 | 9.03 | 3.54 | 3.48 | 3.19 |
Other Intangible Assets | 143.85 | 149.69 | 161.37 | 173.05 | 159.7 | 70.54 |
Other Long-Term Assets | 9.92 | 7.61 | 2.62 | 2.26 | 21.76 | 57.28 |
Total Assets | 2,056 | 1,358 | 1,393 | 1,662 | 1,638 | 2,271 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 99.04 | 77.2 | 338.03 | 246.38 | 290.41 | 414.29 |
Accrued Expenses | - | 172.4 | 195.23 | 372.28 | 400.87 | 400.65 |
Current Portion of Long-Term Debt | 151.7 | 185.9 | 60.8 | 105.99 | 8.57 | 30.7 |
Current Portion of Leases | 15.92 | 5.69 | 32.42 | 33.33 | 36.35 | 13.25 |
Current Income Taxes Payable | - | 2.52 | 1.77 | 17.66 | 5.82 | 24.29 |
Current Unearned Revenue | 10.39 | 10.39 | 10.39 | 6.89 | 7 | 7.45 |
Other Current Liabilities | 227.58 | 56.14 | 43.37 | 67.82 | 197.46 | 42.31 |
Total Current Liabilities | 504.62 | 510.22 | 682.01 | 850.34 | 946.48 | 932.95 |
Long-Term Debt | 189.25 | 156.5 | 257.4 | 213 | 218.99 | 115.81 |
Long-Term Leases | 0.37 | 0.43 | 5.36 | 11.14 | 22.39 | 14.44 |
Long-Term Unearned Revenue | 69.25 | 74.45 | 84.83 | 61.97 | 1.25 | 1.25 |
Other Long-Term Liabilities | - | - | - | 68.73 | - | - |
Total Liabilities | 763.49 | 741.6 | 1,030 | 1,205 | 1,189 | 1,064 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 1.08 | 1 | 0.86 | 0.86 | 0.8 | 0.8 |
Additional Paid-In Capital | - | 9,702 | 9,004 | 8,992 | 8,628 | 8,465 |
Retained Earnings | - | -9,548 | -9,111 | -9,020 | -8,652 | -7,750 |
Treasury Stock | -18.63 | -0 | -0.01 | -0.01 | -0 | -0.01 |
Comprehensive Income & Other | 1,310 | 461.88 | 469.99 | 483.25 | 473.09 | 491.44 |
Total Common Equity | 1,293 | 616.77 | 363.87 | 456.83 | 449.33 | 1,207 |
Shareholders' Equity | 1,293 | 616.77 | 363.87 | 456.83 | 449.33 | 1,207 |
Total Liabilities & Equity | 2,056 | 1,358 | 1,393 | 1,662 | 1,638 | 2,271 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 357.24 | 348.52 | 355.97 | 363.45 | 286.29 | 174.2 |
Net Cash (Debt) | 1,269 | 613.97 | 363.91 | 685.07 | 861.31 | 1,604 |
Net Cash Growth | 324.76% | 68.72% | -46.88% | -20.46% | -46.32% | -54.00% |
Net Cash Per Share | 0.85 | 0.44 | 0.29 | 0.54 | 0.73 | 1.38 |
Filing Date Shares Outstanding | 1,521 | 1,474 | 1,277 | 1,275 | 1,198 | 1,173 |
Total Common Shares Outstanding | 1,521 | 1,474 | 1,277 | 1,275 | 1,198 | 1,173 |
Working Capital | 1,303 | 602.97 | 407.9 | 479.45 | 300.44 | 1,025 |
Book Value Per Share | 0.85 | 0.42 | 0.28 | 0.36 | 0.38 | 1.03 |
Tangible Book Value | 1,149 | 467.08 | 202.51 | 283.79 | 289.63 | 1,136 |
Tangible Book Value Per Share | 0.76 | 0.32 | 0.16 | 0.22 | 0.24 | 0.97 |
Machinery | - | 14.79 | 13.79 | 14.11 | 19.1 | 18.95 |
Construction In Progress | - | 151.75 | 151.75 | 151.75 | 151.76 | 138.67 |
Leasehold Improvements | - | 21.28 | 21.28 | 21.28 | 21.28 | 20.31 |